Evidence map›Paper›PMID 26296089›Full record

ArticlePloS one2015

Psychosocial Care Needs of Melanoma Survivors: Are They Being Met?

Sabine Fischbeck, Barbara H Imruck, Maria Blettner, Veronika Weyer, Harald Binder, Sylke R Zeissig, Katharina Emrich, Peter Friedrich-Mai, Manfred E Beutel

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06767332 (EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma), which is not on this map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06767332 narecruitingnot on this mapstarted 2023, after this paper: background citation

EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control Trial

TypeinterventionalSponsorLeiden University Medical CenterRan2023 to 2025Enrolled30ConditionsFamilial Melanoma, Fear of Cancer Recurrence, Eye Movement Desensitization and Reprocessing, Psychological InterventionArmseye movement desensitization and reprocessing (EMDR)
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Primary Cutaneous Melanoma-Management in 2024.Journal of clinical medicine · 2024
    Article
  3. Cross-sectional study of sex differences in psychosocial quality of life of long-term melanoma survivors.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  4. Article
  5. Factors contributing to cancer worry in the skin cancer population.Journal of the American Academy of Dermatology · 2020
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Variations in supportive care needs of patients after diagnosis of localised cutaneous melanoma: a 2-year follow-up study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Sabine FischbeckDepartment of Psychosomatic Medicine and Psychotherapy, Medical Psychology and Medical Sociology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Barbara H ImruckDepartment of Psychosomatic Medicine and Psychotherapy, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Maria BlettnerInstitute for Medical Biometrics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Veronika WeyerInstitute for Medical Biometrics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Harald BinderInstitute for Medical Biometrics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Sylke R ZeissigInstitute for Medical Biometrics, Epidemiology and Informatics (IMBEI), Cancer Registry, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Katharina EmrichInstitute for Medical Biometrics, Epidemiology and Informatics (IMBEI), Cancer Registry, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Peter Friedrich-MaiDepartment of Psychosomatic Medicine and Psychotherapy, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Manfred E BeutelDepartment of Psychosomatic Medicine and Psychotherapy, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
University Medical Center of the Johannes Gutenberg University Mainz · DEJohannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients who have survived malignant melanoma for more than five years may lack the opportunity to talk about their burden. As a consequence their psychosocial care needs remain undetected and available supportive interventions may not be utilised. Therefore, the psychosocial burden of this patient group needs to be assessed using specific screening instruments. The aim of this study was to investigate the psychosocial burden of long-term melanoma survivors, their psychosocial care needs and the determinants of these needs. We wanted to find out if the use of professional support corresponds to the care needs defined by experts. Using the cancer registry of Rhineland-Palatinate, melanoma patients diagnosed at least 5 years before the survey were contacted by physicians. N = 689 former patients completed the Hornheide Questionnaire (short form HQ-S) to identify psychosocial support need (scale cut off ≥ 16 or item-based cut-off score) and the potential psychosocial determinants of these needs. Additionally, they were asked about their utilisation of the professional support system. More than one third (36%) of them was in need for professional psychosocial support. The highest burden scores concerned worry about tumour progression. Younger age (< 50), higher general fatigue, higher symptom burden, lower general health, negative social interactions and unfulfilled information needs were significant predictors of the need for psychosocial intervention. Related to the percentage of survivors identified as 'in need', the professional support system was underused. Further studies should investigate whether using the HQ-S to routinely identify burdened melanoma patients could lead to better fulfilment of their intervention needs, ultimately enhancing health-related quality of life.

Indexed as

AdultAgedAnxietyCutaneous Malignant MelanomaFemaleHealth Services MisuseHealth Services Needs and DemandHumansMaleMelanomaMiddle AgedQuality of LifeSkin NeoplasmsSocial SupportSurveys and QuestionnairesSurvivors

Identifiers

PMID26296089
PMCPMC4546620
OpenAlexW1191295727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.